Results 121 to 130 of about 81,953 (294)

Cryptococcal meningitis due to Cryptococcus neoformans VNI in a koala (Phascolarctos cinereus) with progressive neurological disease

open access: yesAustralian Veterinary Journal, EarlyView.
Nearly all cases of cryptococcosis in koalas are caused by Cryptococcus gattii species complex. A rare case of meningitis due to Cryptococcus neoformans VNI/AFLP1 (abbreviated VNI) is described in a koala with nasal colonisation by both species complexes.
A Teh   +6 more
wiley   +1 more source

Immunophenotyping in Vernal Keratoconjunctivitis: Schirmer Test for Therapy Response Prediction

open access: yes
Allergy, EarlyView.
Maria Teresa Bilotta   +9 more
wiley   +1 more source

Efficacy and safety of HRS‐5965 monotherapy in complement inhibitor–naïve patients with paroxysmal nocturnal haemoglobinuria

open access: yesBritish Journal of Haematology, EarlyView.
Summary Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, life‐threatening disorder characterized by complement‐mediated haemolysis, leading to anaemia and thrombosis. HRS‐5965 is a novel, oral, selective complement factor B inhibitor targeting the alternative pathway, potentially reducing both intra‐ and extravascular haemolysis.
Li Zhang   +7 more
wiley   +1 more source

Look past the cooperative eye hypothesis: reconsidering the evolution of human eye appearance

open access: yesBiological Reviews, EarlyView.
ABSTRACT The external appearance of the human eye has been prominently linked to the evolution of complex sociocognitive functions in our species. The cooperative eye hypothesis (CEH) proposes that human eyeballs, with their weakly expressed conjunctival and scleral pigmentation, are uniquely conspicuous and evolved under selective pressures to behave ...
Juan Olvido Perea‐García   +2 more
wiley   +1 more source

Long‐Term Morphological Changes of Crosslinked Gelatin Stent

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background This study investigates the long‐term morphological outcomes of crosslinked gelatin stents over a 10‐year period. Methods Participants from the FDA phase 1 and 2 trials for the XEN 140 stent were recalled for follow‐up examinations between 9 and 12 years after their initial implantation.
Yuen Keat Gan   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy